Therefore, future studies investigating the pathways dysregulated in FTD patients with other common mutations including MAPT, FUS, CHMP2B mutation and will be important to understand the underlying mechanisms in different genetic forms of FTD. This evidence concerns the gene CHMP2B and frontotemporal dementia.